Abstract
The compounds described herein were designed and synthesized at the Salk Institute for Biological Studies. The chemical synthesis for the specific compounds described in this article can be found in a recently published paper (J. Med. Chem. 55:378-389, 2012). The neuroprotection assays presented in this paper were conducted at the Salk Institute in collaboration with Cedars-Sinai Medical Center under a subcontract to NINDS grant NS060685 (PI Lapchak)
Current Pharmaceutical Design
Title:Corrigendum
Volume: 19 Issue: 3
Author(s): Paul A. Lapchak
Affiliation:
Abstract: The compounds described herein were designed and synthesized at the Salk Institute for Biological Studies. The chemical synthesis for the specific compounds described in this article can be found in a recently published paper (J. Med. Chem. 55:378-389, 2012). The neuroprotection assays presented in this paper were conducted at the Salk Institute in collaboration with Cedars-Sinai Medical Center under a subcontract to NINDS grant NS060685 (PI Lapchak)
Export Options
About this article
Cite this article as:
A. Lapchak Paul, Corrigendum, Current Pharmaceutical Design 2013; 19 (3) . https://dx.doi.org/10.2174/1381612811306030527
DOI https://dx.doi.org/10.2174/1381612811306030527 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Nuclear Steroid Receptors in Apoptosis
Current Medicinal Chemistry Nitric Oxide and Arginine Dysregulation: A Novel Pathway to Pulmonary Hypertension in Hemolytic Disorders
Current Molecular Medicine Efficacy and Cardiovascular Safety of Alpha Glucosidase Inhibitors
Current Drug Safety Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors
Current Clinical Pharmacology Ivabradine: a Selective If Current Inhibitor in the Treatment of Stable Angina
Recent Patents on Cardiovascular Drug Discovery Cofilin/Actin Rod Formation by Dysregulation of Cofilin-1 Activity as a Central Initial Step in Neurodegeneration
Mini-Reviews in Medicinal Chemistry The Renin-Angiotensin System in the Mammalian Central Nervous System
Current Protein & Peptide Science Architectural Changes of Thigh Muscles in Patients with Subacute Stroke after Body Weight Support Treadmill Training
Current Medical Imaging Uteroplacental Circulation and Fetal Vascular Function and Development
Current Vascular Pharmacology Editorial: Current Scenario on Natural Products Chemistry
Cardiovascular & Hematological Agents in Medicinal Chemistry Separation of Ginseng Active Ingredients and their Roles in Cancer Metastasis Supplementary Therapy
Current Drug Metabolism Preconditioning of the Myocardium by Volatile Anesthetics
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies
Current Drug Targets Pharmaceutical Aspects of Hemoglobin-Based Oxygen Carriers
Current Drug Delivery Interleukin-18, From Neuroinflammation to Alzheimers Disease
Current Pharmaceutical Design Formulation and Ex Vivo Evaluation of Buccal Tablets of Isradipine in a β- Cyclodextrin Complex to Improve the Photostability
Current Drug Therapy Epilepsy, Comorbidities and Treatments
Current Pharmaceutical Design Angiotensin Receptor Blockers in Hypertension and Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Identifying Risk Factors for Clinically Significant Diabetic Macula Edema in Patients with Type 2 Diabetes Mellitus
Current Diabetes Reviews Magnetic Nanoparticles for MRI of Brain Tumors
Current Pharmaceutical Biotechnology